PEAK6 Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,000
Closed -$1.1M 4490
2024
Q1
$1.1M Sell
16,000
-27,400
-63% -$1.85M ﹤0.01% 1861
2023
Q4
$2.7M Buy
43,400
+16,700
+63% +$934K 0.01% 1278
2023
Q3
$1.5M Buy
+26,700
New +$1.5M 0.01% 1542
2022
Q2
Sell
-3,700
Closed -$232K 6634
2022
Q1
$232K Buy
+3,700
New +$199K ﹤0.01% 3763
2021
Q4
Sell
-1,300
Closed -$85K 5937
2021
Q3
$85K Sell
1,300
-100
-7% -$6.83K ﹤0.01% 4416
2021
Q2
$89K Buy
+1,400
New +$82.6K ﹤0.01% 4447
2021
Q1
Sell
-7,600
Closed -$379K 5676
2020
Q4
$379K Buy
+7,600
New +$357K ﹤0.01% 3321

Other funds holding AXNX

PEAK6 Investments's AXNX Position: Q2 2022 in Review

PEAK6 Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2022, closing a stake of 3,541 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in AXNX in Q2 2020 and held it in 6 quarters. The position peaked at $1.29M in Q4 2020. 196 funds tracked by Wall St. Rank hold AXNX as of Q2 2022.

  • PEAK6 Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • PEAK6 Investments sold 3,541 Axonics, Inc. Common Stock shares in Q2 2022, an estimated $222K.
  • PEAK6 Investments first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • PEAK6 Investments's Axonics, Inc. Common Stock position peaked at $1.29M in Q4 2020.
  • 196 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.